Description

Hydralazine Inj-India is a vasodilator injection used to treat high blood pressure (hypertension) and heart failure.

Prescription

• Prescription-only medicine (POM)

Dosage

•  Initial dose: 20-40mg IV or IM, repeated as needed
•  Maintenance dose: 20-50mg IV or IM every 4-6 hours

Therapeutic Category

• Antihypertensive, Vasodilator

Active Ingredients/Composition

•  Hydralazine hydrochloride 20mg/mL
•  Other ingredients: Sodium chloride, Water

Variant

•  Hydralazine HCL Tablets
•  Hydralazine HCL Oral Solution

Consume Type

• Injectable medication

Directions/Usage

•  Administer by slow IV injection or deep IM injection.
•  Monitor blood pressure and adjust dosage as needed.

Common Side Effects

•  Headache
•  Dizziness
•  Nausea
•  Vomiting
•  Tachycardia (rapid heart rate)

Package Type

• Vial or ampoule containing 20mg/mL hydralazine HCL injection

Storage Advice

•  Store at room temperature (15-30°C/59-86°F).
•  Protect from light and heat sources.
•  Do not freeze.

Safety Advice

•  Use as directed by a healthcare professional.
•  Monitor blood pressure and heart rate regularly.
•  Be aware of signs of overdose, such as severe headache, confusion, and seizures.

Product Substitutes

•  Other vasodilators (e.g., minoxidil, diazoxide)
•  Other antihypertensive medications (e.g., beta blockers, ACE inhibitors)

Manufacturer/Marketer

•  Name: Various Indian pharmaceutical companies (e.g., Cipla, Lupin, Torrent)
•  Reputation: Reputable pharmaceutical companies

Country of Origin

•  India